This is of particular relevance as CD8+ NKG2A+ T cells constitute the majority of NKG2A+ cells in human lung cancer and are more prevalent than in the blood of patients and compared to healthy lung tissue [69]. The gene discussed is KLRC1; the disease is lung carcinoma.